ProMIS Neurosciences
PMN | NASDAQ
$3.31
+$0.02 (+0.61%)
At close: Nov 16, 2026, 4:00 PM ET
$3.20
-$0.11 (-3.32%)
After-hours:
Nov 16, 2026, 7:48 PM ET
+0.61%
(1D)No price chart data available for 1D timeframe.
Rating
24.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #947/1021 (Top 93%)
Key Statistics
Market Data
Market Cap $29.78M
1D Range
3.15 3.49
52W Range
3.00 24.79
Valuation (TTM)
PE -0.35
PB 0.71
EV/EBITDA 0.36
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $31.00
Cash Flow
FCF Yield -138.3%
SBC Adj. FCF Yield -3019.1%
SBC Impact -2082.3%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
-140.9%
Dil EPS 3Y | 5Y -19.9% |
45.0%
FCF 3Y | 5Y -31.7% |
-20.6%
Returns
ROA -82.3%
ROE -103.1%
ROIC -96.4%
Financial Health
Net Cash
$44.11M
Current Ratio 8.83
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
ProMIS Neurosciences, Inc. is a Canadian biotechnology firm dedicated to creating targeted therapeutic solutions for debilitating neurodegenerative conditions such as Alzheimer's disease (AD), amyotro...
Sector Healthcare
Industry Biotechnology
Employees 11
IPO Date Jan 10, 2007
Website www.promisneurosciences.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
4
Consensus
Buy
Price Target
$31.00
Upside
+836.56%
Buy (4)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove PMN